Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.54 |
| ▸ | TKT | P29401 | 11/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL18879467 | 0.90 | HSP90AA1 (0.60) | HSP90AA1TKTKDM4ETDP1 | |
| Hydrochloric Acid SCHEMBL2949884 | 0.78 | TKT (0.69) | HSP90AA1TKTKDM4ETDP1 | |
| Hydrochloric Acid SCHEMBL14637039 | 0.77 | HSP90AA1 (0.61) | HSP90AA1TKTKDM4ETDP1 | |
| SCHEMBL13741567 | 0.77 | TKT (0.68) | HSP90AA1TKTKDM4ETDP1 | |
| Hydrochloric Acid SCHEMBL5940670 | 0.75 | HSP90AA1 (0.57) | HSP90AA1TKTKDM4ETDP1 | |
| Hydrochloric Acid SCHEMBL4355811 | 0.74 | TKT (0.70) | HSP90AA1TKTKDM4ETDP1 | |
| SCHEMBL13741845 | 0.72 | TKT (0.71) | HSP90AA1TKTKDM4ETDP1 | |
| Thiamine Ion SCHEMBL7746990 | 0.72 | HSP90AA1 (0.93) | HSP90AA1TKTKDM4ETDP1 | |
| Thiamine Ion SCHEMBL10074 | 0.71 | HSP90AA1 (0.98) | HSP90AA1TKTKDM4ETDP1 | |
| Thiamine Ion SCHEMBL7090274 | 0.71 | HSP90AA1 (0.98) | HSP90AA1TKTKDM4ETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250243436-A1 | METHOD FOR PRODUCING AGAVE CULTURES FOR TEQUILA | PHYTO TEQ, INC. (US) | 2025-07-31 | — | — | US | claimed |
| US-20250243437-A1 | METHOD FOR PRODUCING AGAVE CULTURES FOR TEQUILA | PHYTO TEQ, INC. (US) | 2025-07-31 | — | — | US | claimed |
| EP-4482300-A1 | METHOD FOR PRODUCING AGAVE CULTURES FOR TEQUILA | Phyto Teq, Inc. (US) | 2025-01-01 | — | — | EP | claimed |
| CN-118870969-A | Method for producing agave cultures for agave wine | 弗陶特克有限公司 | 2024-10-29 | — | — | CN | claimed |
| US-20240141264-A1 | METHOD FOR PRODUCING AGAVE CULTURES FOR TEQUILA | PHYTOTEQ, INC. | 2024-05-02 | — | — | US | claimed |
| US-11895962-B2 | Method for producing agave cultures for tequila | PHYTOTEQ, INC. (US) | 2024-02-13 | — | — | US | claimed |
| WO-2023163747-A1 | METHOD FOR PRODUCING AGAVE CULTURES FOR TEQUILA | PHYTOTEQ, INC. (US) | 2023-08-31 | — | — | WO | claimed |
| US-20230263120-A1 | METHOD FOR PRODUCING AGAVE CULTURES FOR TEQUILA | PHYTOTEQ, INC. (US) | 2023-08-24 | — | — | US | claimed |
| EP-3551201-A1 | METHODS AND COMPOSITIONS RELATING TO ISOLATED AND PURIFIED MICROBES | Pendulum Therapeutics, Inc. (US) | 2019-10-16 | — | — | EP | claimed |
| WO-2018106844-A1 | METHODS AND COMPOSITIONS RELATING TO ISOLATED AND PURIFIED MICROBES | WHOLE BIOME INC. (US) | 2018-06-14 | — | — | WO | claimed |
| US-12618029-B2 | Method for producing agave cultures for tequila | PHYTOTEQ, INC. (US) | 2026-05-05 | — | — | US | disclosed |
| EP-4707402-A1 | BIOELECTROCHEMICAL HYDROXYLATION OF SUBSTRATES USING FUNCTIONAL WATER-DEPENDENT ALKYL-HYDROXYLASE HYBRID ELECTRODES AND RESPECTIVE BIOFILM HYBRID ELECTRODES | Albert-Ludwigs-Universität Freiburg Körperschaft des öffentlichen Rechts (DE) | 2026-03-11 | — | — | EP | disclosed |
| US-12544412-B2 | Methods and compositions relating to microbial treatment and diagnosis of disorders | PENDULUM THERAPEUTICS INC (US) | 2026-02-10 | — | — | US | disclosed |
| US-20250243436-A1 | METHOD FOR PRODUCING AGAVE CULTURES FOR TEQUILA | PHYTO TEQ, INC. (US) | 2025-07-31 | — | — | US | disclosed |
| US-20250243437-A1 | METHOD FOR PRODUCING AGAVE CULTURES FOR TEQUILA | PHYTO TEQ, INC. (US) | 2025-07-31 | — | — | US | disclosed |
| WO-1993010802-A1 | AQUEOUS SYNTHETIC ORGAN EXTRACTS | RIEMSCHNEIDER RANDOLPH (DE) | 1993-06-10 | — | — | WO | disclosed |
| EP-0166903-B1 | PROCESS FOR THE PRODUCTION BY FERMENTATION OF BRANCHED ALIPHATIC OR AROMATIC L-AMINO ACIDS FROM ALPHA-KETOCARBOXYLIC ACIDS | Degussa Aktiengesellschaft (DE) | 1991-03-06 | — | — | EP | disclosed |
| EP-0166903-A2 | Process for the production by fermentation of branched aliphatic or aromatic L-amino acids from alpha-ketocarboxylic acids | Degussa Aktiengesellschaft (DE) | 1986-01-08 | — | — | EP | disclosed |
| EP-0084522-A2 | Plasmids and bacteria strains, and method of preparing the same | SANDOZ AG (CH) | 1983-07-27 | — | — | EP | disclosed |
| WO-1983002456-A2 | NEW PLASMIDS AND BACTERIAL STRAINS AND PRODUCTION PROCESS THEREO F | CESKA, MIROSLAV | 1983-07-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12544412-B2 | Methods and compositions relating to microbial treatment and diagnosis of disorders | MUC1, SPOUT1, TAS2R14 | HSP90AA1 3354/4885TKT 142/4885KDM4E 2088/4885 |
| US-12618029-B2 | Method for producing agave cultures for tequila | ALAD, TFEB, MYB | HSP90AA1 1666/4885TKT 258/4885KDM4E 840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.